stockrow
Friday 6 November 2026
Export DXR’s income statement to Excel — free account
Daxor Corporation
DXR Healthcare Medical Instruments & Supplies
Daxor Corporation’s revenue for fiscal 2022 (year ended December 2022) was −$353,400.00.
8.56
0.07
−0.81%
Follow DXR
Alert me
| Jun '23 | Dec '22 | Jun '22 | Dec '21 | Older periods | |
|---|---|---|---|---|---|
| 37.62% | 44.47% | 31.06% | 17.94% |
+7 more TTM periods Free account |
|
| 35.90% | 42.41% | 25.53% | 15.53% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(1.68) | (1.55) | (1.49) | (1.40) | |
Free Cash Flow |
(7.52) | (6.29) | (6.02) | (5.65) | |
| Other line items | |||||
Cash ROIC |
(24.77%) | (20.84%) | (26.86%) | (22.70%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
(0.89) | (0.63) | (1.26) | (1.86) | |
Revenue per Share |
(0.75) | (0.73) | (1.02) | (1.34) | |
Operating CF per Share |
(1.68) | (1.55) | (1.49) | (1.40) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates